1. Home
  2. PLG vs CATX Comparison

PLG vs CATX Comparison

Compare PLG & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Platinum Group Metals Ltd. (Canada)

PLG

Platinum Group Metals Ltd. (Canada)

N/A

Current Price

$0.86

Market Cap

140.7M

Sector

N/A

ML Signal

N/A

Logo Perspective Therapeutics Inc.

CATX

Perspective Therapeutics Inc.

N/A

Current Price

$0.78

Market Cap

113.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PLG
CATX
Founded
2000
1983
Country
Canada
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
140.7M
113.9M
IPO Year
2002
2018

Fundamental Metrics

Financial Performance
Metric
PLG
CATX
Price
$0.86
$0.78
Analyst Decision
Strong Buy
Analyst Count
0
16
Target Price
N/A
★ $9.43
AVG Volume (30 Days)
1.1M
★ 4.2M
Earning Date
11-30-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$91.56
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.90
$0.78
52 Week High
$4.04
$6.16

Technical Indicators

Market Signals
Indicator
PLG
CATX
Relative Strength Index (RSI) 28.65 24.41
Support Level N/A N/A
Resistance Level $1.44 $2.40
Average True Range (ATR) 0.07 0.12
MACD -0.01 0.04
Stochastic Oscillator 4.61 1.91

Price Performance

Historical Comparison
PLG
CATX

About PLG Platinum Group Metals Ltd. (Canada)

Platinum Group Metals Ltd is a development-stage company, conducts work on mineral properties it has staked or acquired by way of option agreements in the Republic of South Africa. Key metals of economic interest on the company's mineral properties include platinum, palladium, rhodium, gold, copper, and nickel. The company operates in one segment, the development of the Waterberg Project in South Africa, and geographically in Canada and South Africa.

About CATX Perspective Therapeutics Inc.

Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.

Share on Social Networks: